Hanson Kristopher 4

What Happened

• Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), sold a total of 13,917 shares in open-market transactions on May 4, 2026, generating aggregate proceeds of $388,177.
• Individual sales reported:
  • 9,030 shares @ weighted avg $27.50 — $248,325 (F2; trades ranged $26.84–$27.835)
  • 3,908 shares @ weighted avg $28.29 — $110,557 (F3; trades ranged $27.845–$28.73)
  • 296 shares @ weighted avg $29.56 — $8,750 (F4; trades ranged $29.00–$29.9669)
  • 683 shares @ weighted avg $30.08 — $20,545 (F5; trades ranged $30.00–$30.55)
• These were sales (code "S"), which are generally routine dispositions rather than purchases that might signal conviction.

Key Details

• Transaction date: May 4, 2026; Form 4 filed May 6, 2026 (filed within the standard two-business-day window).
• Total shares sold: 13,917; total proceeds: $388,177.
• Shares owned after transaction: not disclosed in the provided filing.
• Notable footnotes:
  • F1: Transactions were made pursuant to a Rule 10b5-1 trading plan adopted December 29, 2025 (pre-established plan).
  • F2–F5: Reported prices are weighted averages; each footnote gives the per-trade price ranges and the filer offers to supply the breakdown on request.
• Transaction type: S = Sale.

Context

• 10b5-1 plans are pre-set trading arrangements that allow insiders to sell according to an established schedule; trades under such plans are commonly considered routine and are designed to avoid allegations of trading on material nonpublic information.
• Sales do not necessarily indicate negative views of the company; purchases are typically more informative about insider sentiment.